Literature DB >> 9361418

Stabilization of apoglobin by low temperature increases yield of soluble recombinant hemoglobin in Escherichia coli.

M J Weickert1, M Pagratis, S R Curry, R Blackmore.   

Abstract

Accumulation of soluble recombinant hemoglobin (rHb1.1) in Escherichia coli requires proper protein folding, prosthetic group (heme) addition, and subunit assembly. This served as a new model system for the study of the effects of temperature, protein synthesis rates, and protein accumulation rates on protein solubility in E. coli. Fermentation expression of rHb1.1 at 30 degrees C from cultures containing a medium or high globin gene dosage (pBR-based or pUC-based plasmids with rHb1.1 genes under the control of the tac promoter) was compared. A medium gene dosage resulted in rHb1.1 accumulating to approximately 7% of the soluble cell protein, of which 78% was soluble. A high globin gene dosage resulted in a > or = 3-fold increase in total globin to 23 to 24% of the soluble cell protein, but 70% was insoluble. Accumulation of insoluble rHb1.1 began immediately upon induction. The proportion of rHb1.1 from the high globin gene dosage that accumulated as insoluble globin was affected by reducing (i) the inducer concentration and (ii) the temperature. Reducing the inducer concentration reduced globin synthesis up to eightfold but increased the proportion of soluble rHb1.1 to 93%. In contrast, total globin protein synthesis was barely affected by reducing the temperature from 30 to 26 degrees C, while soluble globin accumulation increased > 2-fold to approximately 15% of the soluble cell protein. The contrast between the effects of reducing rates of protein synthesis and accumulation and those of reducing temperature suggests that lower temperature stabilizes one or more folding intermediates. We propose a simplified physical model which integrates protein synthesis, folding, and heme association. This model shows that temperature-dependent apoglobin stability is the most critical factor in soluble rHb1.1 accumulation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9361418      PMCID: PMC168751          DOI: 10.1128/aem.63.11.4313-4320.1997

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  32 in total

1.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

2.  Hemoglobin sabine beta 91 (f 7) leu to pro. An unstable variant causing severe anemia with inclusion bodies.

Authors:  R G Schneider; S Ueda; J B Alperin; B Brimhall; R T Jones
Journal:  N Engl J Med       Date:  1969-04-03       Impact factor: 91.245

3.  Formation of aggregates from a thermolabile in vivo folding intermediate in P22 tailspike maturation. A model for inclusion body formation.

Authors:  C A Haase-Pettingell; J King
Journal:  J Biol Chem       Date:  1988-04-05       Impact factor: 5.157

4.  The crystal structure of human deoxyhaemoglobin at 1.74 A resolution.

Authors:  G Fermi; M F Perutz; B Shaanan; R Fourme
Journal:  J Mol Biol       Date:  1984-05-15       Impact factor: 5.469

5.  The structure of human carbonmonoxy haemoglobin at 2.7 A resolution.

Authors:  J M Baldwin
Journal:  J Mol Biol       Date:  1980-01-15       Impact factor: 5.469

6.  Haemoglobin Köln (beta-98 valine--methionine): an unstable protein causing inclusion-body anaemia.

Authors:  R W Carrell; H Lehmann; H E Hutchison
Journal:  Nature       Date:  1966-05-28       Impact factor: 49.962

7.  Structure of human oxyhaemoglobin at 2.1 A resolution.

Authors:  B Shaanan
Journal:  J Mol Biol       Date:  1983-11-25       Impact factor: 5.469

8.  Human hemoglobin expression in Escherichia coli: importance of optimal codon usage.

Authors:  R A Hernan; H L Hui; M E Andracki; R W Noble; S G Sligar; J A Walder; R Y Walder
Journal:  Biochemistry       Date:  1992-09-15       Impact factor: 3.162

9.  Kinetics and mechanism of heme-induced refolding of human alpha-globin.

Authors:  Y Leutzinger; S Beychok
Journal:  Proc Natl Acad Sci U S A       Date:  1981-02       Impact factor: 11.205

10.  Control of formation of active soluble or inactive insoluble baker's yeast alpha-glucosidase PI in Escherichia coli by induction and growth conditions.

Authors:  E Kopetzki; G Schumacher; P Buckel
Journal:  Mol Gen Genet       Date:  1989-03
View more
  9 in total

1.  High-fidelity translation of recombinant human hemoglobin in Escherichia coli.

Authors:  M J Weickert; I Apostol
Journal:  Appl Environ Microbiol       Date:  1998-05       Impact factor: 4.792

Review 2.  Development of recombinant hemoglobin-based oxygen carriers.

Authors:  Cornelius L Varnado; Todd L Mollan; Ivan Birukou; Bryan J Z Smith; Douglas P Henderson; John S Olson
Journal:  Antioxid Redox Signal       Date:  2012-11-16       Impact factor: 8.401

3.  Development of a method to produce hemoglobin in a bioreactor culture of Escherichia coli BL21(DE3) transformed with a plasmid containing Plesiomonas shigelloides heme transport genes and modified human hemoglobin genes.

Authors:  B J Z Smith; P Gutierrez; E Guerrero; C J Brewer; D P Henderson
Journal:  Appl Environ Microbiol       Date:  2011-07-29       Impact factor: 4.792

4.  The effects of protein solubility on the RNA Integrity Number (RIN) for recombinant Escherichia coli.

Authors:  Mary Alice Salazar; Lawrence P Fernando; Faraz Baig; Sarah W Harcum
Journal:  Biochem Eng J       Date:  2013-10-15       Impact factor: 3.978

5.  Co-expression of ferrochelatase allows for complete heme incorporation into recombinant proteins produced in E. coli.

Authors:  Jawahar Sudhamsu; Mariam Kabir; Michael V Airola; Bhumit A Patel; Syun-Ru Yeh; Denis L Rousseau; Brian R Crane
Journal:  Protein Expr Purif       Date:  2010-03-18       Impact factor: 1.650

6.  A mutation that improves soluble recombinant hemoglobin accumulation in Escherichia coli in heme excess.

Authors:  M J Weickert; M Pagratis; C B Glascock; R Blackmore
Journal:  Appl Environ Microbiol       Date:  1999-02       Impact factor: 4.792

7.  Soluble expression of human leukemia inhibitory factor with protein disulfide isomerase in Escherichia coli and its simple purification.

Authors:  Jung-A Song; A Song Jung; Bon-Kyung Koo; Seon-Ha Chong; Kyunhoo Kim; Dong Kyu Choi; Thu Trang Thi Vu; Minh Tan Nguyen; Boram Jeong; Han-Bong Ryu; Injune Kim; Yeon Jin Jang; Robert Charles Robinson; Han Choe
Journal:  PLoS One       Date:  2013-12-16       Impact factor: 3.240

8.  Structural investigation of APRs to improve the solubility of outer membrane protease (PgtE) from Salmonella enterica serotype typhi- A multi-constraint approach.

Authors:  Gopinath Samykannu; Princy Vijayababu; Christian Bharathi Antonyraj; Sundarabaalaji Narayanan
Journal:  Biochem Biophys Rep       Date:  2019-12-06

9.  Lower temperature cultures enlarge the effects of Vitreoscilla hemoglobin expression on recombinant Pichia pastoris.

Authors:  Jyh-Ming Wu; Shin-Yao Wang; Wei-Chang Fu
Journal:  Int J Mol Sci       Date:  2012-10-15       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.